Lee-Ann Watanabe
Zinzino Independent Partner
¡Bienvenido! Soy su consultor independiente, aquí para guiarlo en su viaje de salud.
Press releases - miércoles, 16 de septiembre de 2020 10:00 CET
ZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
Zinzino AB (publ) announces today that Nasdaq has approved the Company’s application to move its stock trading to First North Premier Growth Market. The transfer is an important step towards a future listing on Nasdaq’s main market. The trade in Zinzino’s shares on First North Premier Growth Market will be initiated on Monday, September 21, 2020.
“The fact that we are able to move the trade to Premier is an important strategic step in our global expansion, and facilitates institutional and international ownership of Zinzino”, says Dag Bergheim Pettersen, CEO.
The Premier segment of First North Growth Market is targeted to companies that are preparing for a main market listing, with higher disclosure, accounting and corporate governance standards. The requirements for Premier largely comply with the regulations for Nasdaq main market listing, which is a regulated marketplace.
Zinzino reports according to International Financial Reporting Standards, IFRS, a demand for all companies traded on Premier.
Zinzino shareholders do not need to take any action in connection with the listing on First North Premier Growth Market. The share will be traded under the same short name (ZZ B) and ISIN code as before.
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, Florida and Adelaide. Zinzino is a public company and its shares are listed on Nasdaq First North Growth Market.
Compartir esta página
O copiar el link